Clinical Trials in Detroit

Showing 17561-17580 of 19,719 trials

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

NCT01603069

This is a study where AZD3241 or placebo is given to patients with Parkinson's disease in a blinded and randomized assignment. The main objective is to see if safety and tolerability of the drug is acceptable.

Parkinson's Disease

AstraZeneca51 participantsStarted Oct 2012

Birmingham, Alabama, United States • Long Beach, California, United States • New Haven, Connecticut, United States +10 more locations

COMPLETEDPhase 136 miles

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

NCT01199887

This is an open label, Phase One, multicenter study, designed to evaluate the safety, tolerability, to explore the biologic effects, and to explore the clinical effects of the following doses of IW001: 0.1mg/day, 0.5 mg/day, and 1.0 mg/day, when administered once a day orally for 24 weeks in patients with IPF.

Idiopathic Pulmonary Fibrosis

ImmuneWorks30 participantsStarted Sep 2010

Birmingham, Alabama, United States • Miami, Florida, United States • Chicago, Illinois, United States +8 more locations

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

Find Trials by Condition in Detroit

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Occipital Nerve Stimulation in the Treatment of Migraine

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Balloon REmodeling Antrostomy THErapy Study

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer